HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Helene H Heidegger Selected Research

L-161982

3/2021EP4 as a Negative Prognostic Factor in Patients with Vulvar Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Helene H Heidegger Research Topics

Disease

3Neoplasms (Cancer)
03/2021 - 09/2020
2Carcinogenesis
03/2021 - 03/2021
2Carcinoma (Carcinomatosis)
03/2021 - 12/2020
2Inflammation (Inflammations)
03/2021 - 03/2020
2Vulvar Neoplasms (Vulvar Cancer)
03/2021 - 12/2020
1Neoplasm Metastasis (Metastasis)
09/2020
1Uterine Cervical Neoplasms (Cancer of the Cervix)
09/2020
1Gestational Diabetes (Gestational Diabetes Mellitus)
03/2020

Drug/Important Bio-Agent (IBA)

2Bromodeoxyuridine (BrdU)IBA
03/2021 - 12/2020
1L-161982IBA
03/2021
1Prostaglandin Receptors (Prostaglandin Receptor)IBA
03/2021
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
03/2021
1Proteins (Proteins, Gene)FDA Link
12/2020
1Biomarkers (Surrogate Marker)IBA
12/2020
1indoleIBA
12/2020
1sulprostoneIBA
09/2020
1Dinoprostone (PGE2)FDA Link
09/2020
1Plasminogen Activator Inhibitor 1IBA
09/2020
1GTP-Binding Proteins (G-Protein)IBA
09/2020
1Urokinase Plasminogen Activator ReceptorsIBA
09/2020
1Galectin 2 (LGALS2)IBA
03/2020

Therapy/Procedure

2Therapeutics
03/2021 - 12/2020
1Immunomodulation
03/2020